TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
planned
Official procurement procedure

GSS23743: UK Research and Innovation (UKRI) - Antibodies Framework

Chemical products
Laboratory services
Medical consumables
+1 more
UK
Published value
£9,600,000
Submission deadline Not published
Lots published4
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: UK Research and Innovation: "GSS23743: UK Research and Innovation (UKRI) - Antibodies Framework". Published status: planned. Published value: £9,600,000. 4 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityUK Research and InnovationScope & CategoriesNot publishedSubmission Window
planned
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)£9,600,000
Bidder Intelligence · Authority Profile: UK Research and Innovation
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for UK Research and Innovation. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 0 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityUK Research and Innovation
Procedure methodNot published
Procurement categoryNot published
Statusplanned
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published26 Sept 2023, 08:45 BST
Last source update26 Sept 2023, 08:45 BST
Recurring procurementNot published
ClassificationChemical products, Laboratory services, Medical consumables, Research laboratory services
Delivery area
UK
OCIDocds-h6vhtk-040399
What is being bought
***For the avoidance of doubt, this is not a call for competition. This notice is to inform the market of a Future Opportunity*** UK Research and Innovation (UKRI) brings together the seven Research Councils (AHRC, BBSRC, EPSRC, ESRC, MRC, NERC, STFC) plus Innovate UK and a new organisation, Research England. UKRI wishes to establish a Framework for the provision of Antibodies. It is intended that the Framework will be based upon four LOTS: LOT 1 - Primary Unconjugated LOT 2 - Primary Conjugated LOT 3 - Secondary Unconjugated LOT 4 - Secondary Conjugated The objective of this procurement will be to: a) Produce a Framework Agreement that UKRI can easily use and provide a compliant route to market. b) Capture a large percentage of the Antibodies requirements from large value items to low value, high volume items. c) Develop strong relationships with UKRI and Suppliers to ensure that the requirements are captured and value for money is achieved. d) To capture quality management information that will support informed decision making in future procurements. e) To ensure sustainability aspects are considered and integrated into the Framework Agreement. f) To continuously improve and apply best practice procurement that meets the end users' requirements. ****There is no commitment at this stage that the above mentioned opportunity will proceed in its current format**** ***GSS23743 Supplier Day*** In order for Suppliers to obtain an overview of the requirement, UK SBS on behalf of UKRI will be holding a Supplier day on Tuesday 10th October 2023 at 15:00hrs GMT, and Wednesday 11th October 2023 at 14:00hrs GMT. The duration of the Supplier day will be approximately 1 hour and will be held online. If you wish to attend, please complete the attached form: https://forms.office.com/e/xvtvVt4wce confirming your attendance and select your preferred date no later than Friday 6th October 2023 at 14:00hrs GMT. Please note that a maximum of two representatives per organisation is permitted. Following confirmation of attendance, a link to the supplier day will be shared with confirmed attendees. Any information supplied shall not place any supplier at an advantage in a potential procurement process.
What changed
From the official release history
  1. Published value updated to £9,600,000
    26 Sept 2023, 08:45 BST
  2. Status changed to planned
    26 Sept 2023, 08:45 BST
  3. Official notice release published
    26 Sept 2023, 08:45 BST
  4. Buyer information updated
    26 Sept 2023, 08:45 BST
Lots and requirements (4)
Published by the contracting authority
  • Lot 1 · #1
    LOT 1 - Primary Unconjugated
    planned
    Published valueNot published
    UKRI wish to put in place a Framework for the provision of Primary Unconjugated Antibodies
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    LOT 2 - Primary Conjugated
    planned
    Published valueNot published
    UKRI wish to put a Framework in place for the provision of Primary Conjugated Antibodies
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #3
    LOT 3 - Secondary Unconjugated
    planned
    Published valueNot published
    UKRI wish to put in place a Framework for the provision of Secondary Unconjugated Antibodies
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 4 · #4
    LOT 4 - Secondary Conjugated
    planned
    Published valueNot published
    UKRI wish to put in place a Framework for the provision of Secondary Conjugated Antibodies
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    26 Sept 2023, 08:45 BST
Commercial outcome and competition
AwardsNo award published
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

UK Research and Innovation

Contracting authority GB-FTS-87633
View buyer profile
  • UK Research and Innovation
    buyer
    centralPurchasingBody

    Polaris House, North Star Avenue, SWINDON, UK, SN21UH
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published